Cerulean Pharma (CERU) Tops Q3 EPS by 2c
Tweet
Share
E-mailGet Alerts CERU Hot Sheet
Join SI Premium – FREE
Cerulean Pharma (NASDAQ: CERU) reported Q3 EPS of ($0.39), $0.02 better than the analyst estimate of ($0.41).
For earnings history and earnings-related data on Cerulean Pharma (CERU) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley upgrades CDW on stronger AI-driven server demand
- Morgan Stanley Starts Adani Enterprises Ltd. (ADE:IN) at Overweight
- Carnival shares drop despite earnings beat on weak guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
